a-woman-smiling-about-to-take-meds

Medication-assisted treatment in Murfreesboro, TN, combines FDA-approved medications with counseling and behavioral therapies to treat opioid use disorder and alcohol use disorder. According to SAMHSA, combining FDA-approved medications with counseling and behavioral therapies improves patient survival and increases retention in treatment. This approach addresses both the physical and psychological aspects of addiction, helping people stabilize so they can engage fully in therapy.

T.R.U.E. Addiction & Behavioral Health provides MAT as part of our outpatient addiction treatment programs for adults ages 18 to 65 in Murfreesboro and across Middle Tennessee. We offer MAT within multiple levels of care, allowing clients to receive medication support alongside evidence-based therapy.

What Is Medication-Assisted Treatment?

Medication-assisted treatment uses medications approved by the U.S. Food and Drug Administration to treat substance use disorders, combined with counseling and behavioral therapies. According to SAMHSA’s guidance on MAT, this whole-patient approach treats the person rather than just the addiction, addressing underlying causes while managing withdrawal symptoms and cravings.

MAT works by normalizing brain chemistry, blocking the euphoric effects of opioids or alcohol, relieving physiological cravings and stabilizing body functions. The medications used in MAT do not create a new addiction; they help restore balance so people can focus on recovery. These medications are an important element of treatment for many patients, especially when combined with counseling and other behavioral therapies.

a-doctor-going-over-medication-instructions

Who Can Benefit From Medication-Assisted Treatment?

MAT is used to treat opioid use disorder and alcohol use disorder in adults. It can be a fit for someone who is addicted to prescription opioids such as oxycodone, heroin, or fentanyl, and for someone whose drinking has become difficult to control. It is also an option for people who have tried to stop on their own and found that cravings or withdrawal symptoms made it hard to stay stopped.

Substance use often occurs alongside anxiety, depression, trauma, or other mental health conditions. T.R.U.E. treats substance use disorders, mental health conditions, and co-occurring disorders, so medication can be paired with dual diagnosis treatment when a client needs both.

a-woman-smiling-in-therapy-session

What Medications Does T.R.U.E. Use for MAT?

T.R.U.E. Addiction & Behavioral Health uses several FDA-approved medications depending on each client’s needs and the substance being treated. Our clinical team works with each person to determine which medication fits their situation. Medications available at T.R.U.E. include:

  • Suboxone (buprenorphine with naloxone)
  • Sublocade (extended-release buprenorphine injection)
  • Buprenorphine without naloxone
  • Naltrexone (oral)
  • Vivitrol (extended-release naltrexone injection)
  • Clonidine for withdrawal symptom management

For opioid use disorder, T.R.U.E. prescribes buprenorphine-based medications including Suboxone and Sublocade. According to the FDA, buprenorphine is a partial opioid agonist that reduces cravings and withdrawal symptoms without producing the full effects of opioids like fentanyl or heroin. Sublocade is a monthly injection that provides steady medication levels, which can help people who have difficulty taking daily medication.

Naltrexone, available as a daily pill or monthly Vivitrol injection, is another option for opioid use disorder. Naltrexone is an opioid antagonist that blocks opioid receptors, preventing any opioid from producing euphoric effects. Clients must be fully detoxed from opioids before starting naltrexone to avoid precipitated withdrawal.

For alcohol use disorder, T.R.U.E. offers naltrexone in both oral and injectable (Vivitrol) forms. According to NIAAA, naltrexone is available as a pill or injection and helps reduce the urge to drink. It works by blocking the brain’s opioid receptors, which are involved in the pleasurable effects of alcohol.

For alcohol use disorder, Vivitrol is meant for people who are not actively drinking at the time of the first injection. The medical team decides when to start naltrexone. The medication helps reduce cravings and the desire to drink, making it easier to engage in therapy and build recovery skills.

What to Expect When You Start MAT at T.R.U.E.

Starting medication-assisted treatment follows a clear sequence:

  1. Call admissions. The admissions team answers 24 hours a day, discusses your situation, and can verify your insurance benefits before treatment begins.
  2. Complete an assessment. The clinical team reviews your substance use history, medical history, and current medications. Drug and alcohol testing may be part of this step.
  3. Choose a medication plan. The medical team recommends a medication based on the substance being treated and your health history. If you already take Suboxone, Vivitrol, or another MAT medication, the team can continue your current regimen.
  4. Begin your level of care. You are matched to partial hospitalization (PHP), intensive outpatient (IOP), or outpatient care based on where you are today.
  5. Continue with regular medical visits and therapy. The team monitors how you are responding and adjusts treatment as your recovery progresses.

MAT at Each Level of Care

Medication is delivered alongside therapy, and the weekly schedule depends on the level of care.

  • Partial hospitalization (PHP): Clients attend Monday through Saturday for about five hours a day. Each week they meet with a primary therapist and a psychiatric nurse practitioner, and a case manager is part of the care team.
  • Intensive outpatient (IOP): Groups meet Monday through Friday from 9:30 a.m. to 12:30 p.m., with a Saturday make-up option for a missed session.
  • Outpatient: Clients attend two to three times a week for groups that last 90 minutes to three hours. Clients who receive MAT are seen weekly, and individual therapy sessions take place every two to three weeks.

How Does MAT Fit With Therapy at T.R.U.E.?

MAT at T.R.U.E. is integrated into the center’s structured treatment programs rather than offered as a standalone service. Clients receiving MAT participate in therapy through intensive outpatient, partial hospitalization or standard outpatient programming, depending on their clinical needs.

Clients in outpatient programming who receive MAT have weekly medical visits to monitor their medication, assess progress and address any concerns. This regular contact allows the clinical team to adjust treatment as needed. T.R.U.E. uses evidence-based therapies including CBT, DBT and trauma therapy alongside MAT, addressing the root causes of addiction while medication manages physical symptoms.

Therapy and Support Alongside Your Medication

Medication eases cravings and withdrawal symptoms, and therapy addresses the reasons a person started using. Clinicians choose the approach that fits the person in front of them, which can include:

  • Cognitive behavioral therapy (CBT) to identify the thoughts and situations that lead to use
  • Dialectical behavior therapy (DBT) to build skills for managing emotions and distress
  • Motivational interviewing to strengthen commitment to change
  • Relapse prevention to plan for triggers and high-risk situations
  • Contingency management, which rewards progress toward treatment goals
  • Trauma-related counseling for clients whose substance use is connected to past experiences
  • Group therapy and family therapy

Support continues outside the therapy room. Clients can receive naloxone education, peer support, help with social services, employment and vocational support, discharge planning, and access to the alumni program.

Yes, T.R.U.E. accepts clients who are already prescribed Suboxone, Vivitrol or other MAT medications by another provider. Our clinical team will coordinate care and can continue the current medication regimen while the client participates in therapy programming.

Clients transferring their MAT care to T.R.U.E. will meet with the medical team to review their medication history and current dosage. This allows for continuity of care without interruption in treatment.

Start MAT at T.R.U.E.

T.R.U.E. Addiction & Behavioral Health serves adults ages 18 to 65 with substance use disorders, mental health conditions and co-occurring disorders in Murfreesboro and throughout Middle Tennessee. Our admissions team answers calls 24 hours a day to discuss treatment options and verify insurance coverage. Contact T.R.U.E. Addiction & Behavioral Health to talk with our admissions team and start treatment. Call (615) 378-6159 at any hour to speak with admissions. Treatment services run Monday through Saturday, 8 a.m. to 5 p.m.

Frequently Asked Questions

The length of MAT varies by individual and is determined by the client and their treatment team. Some people remain on medication for months, while others continue for years. According to SAMHSA, these medications are safe for long-term use, from months to a lifetime. Talk with your treatment team before stopping.

Many insurance plans cover MAT, though coverage varies by plan, service and beneficiary. Our admissions team at T.R.U.E. can help verify insurance benefits and explain coverage details before treatment begins.

No, T.R.U.E. does not offer methadone. Methadone for opioid use disorder can only be dispensed through federally certified opioid treatment programs, according to SAMHSA regulations. T.R.U.E. provides buprenorphine-based medications and naltrexone, which can be prescribed in outpatient settings.

Yes, MAT is designed to help people function normally in daily life. The medications used in MAT do not cause impairment when taken as prescribed, allowing clients to maintain work, school and family responsibilities during treatment.

Missing a dose of MAT medication can lead to withdrawal symptoms or increased cravings, depending on the medication. Clients should contact their treatment team as soon as possible if they miss a dose to receive guidance on how to proceed safely.

Both contain buprenorphine. Suboxone combines buprenorphine with naloxone and is taken daily. Sublocade is an extended-release buprenorphine injection given monthly. The medical team helps each client decide which option fits their needs and routine.

No. The medications used in MAT are prescribed and monitored by a medical team and are combined with counseling and behavioral therapy. Depending on the medication, they reduce cravings, ease withdrawal symptoms, or block the effects of opioids or alcohol, rather than producing the high that comes with misuse.

Yes. MAT at T.R.U.E. is part of the structured treatment programs rather than a standalone service, so medication is paired with therapy in partial hospitalization, intensive outpatient, or outpatient care.

Yes. T.R.U.E. treats mental health conditions and co-occurring disorders along with substance use, so medication for opioid or alcohol use disorder can be paired with care for conditions such as anxiety, depression, or PTSD. Learn more about dual diagnosis treatment.

Withdrawal management at T.R.U.E. is provided on an outpatient basis. If the clinical team decides that someone needs a higher level of medical care, the team will help that person find the right place.

Family counseling is one of the services T.R.U.E. offers. The admissions team can explain how to include a family member in treatment.